Cargando…

BRD4 inhibition promotes TRAIL-induced apoptosis by suppressing the transcriptional activity of NF-κB in NSCLC

Tumor necrosis factor-related apoptosis inducing ligand (TRAIL) and agonistic antibodies against TRAIL death receptors (DR) can induce apoptosis preferentially in tumor cells while causing virtually no damage to normal cells. However, their therapeutic potential is limited by occurring resistance in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shi, Liu, Xiong, Yu, Hu, Xiaoyan, Wang, Zhihao, Xie, Conghua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2021
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8364464/ https://www.ncbi.nlm.nih.gov/pubmed/34400879 http://dx.doi.org/10.7150/ijms.60776

Ejemplares similares

Kurarinone promotes TRAIL-induced apoptosis by inhibiting NF-κB-dependent cFLIP expression in HeLa cells
por: Seo, Ok-Won, et al.
Publicado: (2012)

Tumor suppressor BLU promotes TRAIL-induced apoptosis by downregulating NF-κB signaling in nasopharyngeal carcinoma
por: Zhou, Jiahui, et al.
Publicado: (2016)

Inhibition of BRD4 inhibits proliferation and promotes apoptosis of psoriatic keratinocytes
por: Sun, Xiaohui, et al.
Publicado: (2021)

α-Tocopheryl succinate sensitises a T lymphoma cell line to TRAIL-induced apoptosis by suppressing NF-κB activation
por: Dalen, H, et al.
Publicado: (2003)

A novel BRD4 inhibitor suppresses osteoclastogenesis and ovariectomized osteoporosis by blocking RANKL-mediated MAPK and NF-κB pathways
por: Liu, Ying, et al.
Publicado: (2021)

Aloin Suppresses Lipopolysaccharide-Induced Inflammatory Response and Apoptosis by Inhibiting the Activation of NF-κB
por: Luo, Xuan, et al.
Publicado: (2018)

TAF15 regulates the BRD4/GREM1 axis and activates the gremlin-1-NF-κB pathway to promote OA progression
por: Du, Xiufan, et al.
Publicado: (2023)

NF-κB/RelA controlled A20 limits TRAIL-induced apoptosis in pancreatic cancer
por: Geismann, Claudia, et al.
Publicado: (2023)

Trichosanthin enhances sensitivity of non-small cell lung cancer (NSCLC) TRAIL-resistance cells
por: You, Chengcheng, et al.
Publicado: (2018)

The BET bromodomain inhibitor, JQ1, facilitates c-FLIP degradation and enhances TRAIL-induced apoptosis independent of BRD4 and c-Myc inhibition
por: Yao, Weilong, et al.
Publicado: (2015)

Upregulation of c-FLIP-short in response to TRAIL promotes survival of NSCLC cells, which could be suppressed by inhibition of Ca(2+)/calmodulin signaling
por: Kaminskyy, V O, et al.
Publicado: (2013)

miR-133a Promotes TRAIL Resistance in Glioblastoma via Suppressing Death Receptor 5 and Activating NF-κB Signaling
por: Wang, Shan-shan, et al.
Publicado: (2017)

BRD4 promotes tumor progression and NF-κB/CCL2-dependent tumor-associated macrophage recruitment in GIST
por: Mu, Jianfeng, et al.
Publicado: (2019)

Bromodomain Protein BRD4-Mediated Mutant p53 Transcription Promotes TNBC Progression
por: Zhou, Julie Xia, et al.
Publicado: (2022)

BET Family Protein BRD4: An Emerging Actor in NFκB Signaling in Inflammation and Cancer
por: Hajmirza, Azadeh, et al.
Publicado: (2018)

Glioblastoma Mesenchymal Transition and Invasion are Dependent on a NF-κB/BRD2 Chromatin Complex
por: Vadla, Raghavendra, et al.
Publicado: (2023)

NF-κB targeting by way of IKK inhibition sensitizes lung cancer cells to adenovirus delivery of TRAIL
por: Aydin, Cigdem, et al.
Publicado: (2010)

Suppression of Steady-state, but not Stimulus-induced NF-κB Activity Inhibits Alphavirus-induced Apoptosis
por: Lin, Kuo-I, et al.
Publicado: (1998)

Isoflurane suppresses lung ischemia-reperfusion injury by inactivating NF-κB and inhibiting cell apoptosis
por: Lv, Ning, et al.
Publicado: (2020)

Piceatannol suppresses inflammation and promotes apoptosis in rheumatoid arthritis-fibroblast-like synoviocytes by inhibiting the NF-κB and MAPK signaling pathways
por: Gao, Xuezhong, et al.
Publicado: (2022)

OSMI-1 Enhances TRAIL-Induced Apoptosis through ER Stress and NF-κB Signaling in Colon Cancer Cells
por: Lee, Su-Jin, et al.
Publicado: (2021)

BRD9 inhibition promotes PUMA-dependent apoptosis and augments the effect of imatinib in gastrointestinal stromal tumors
por: Mu, Jianfeng, et al.
Publicado: (2021)

Sulindac inhibits tumor cell invasion by suppressing NF-κB mediated transcription of microRNAs
por: Li, Xiaobo, et al.
Publicado: (2012)

MiR-98 Promotes Apoptosis of Glioma Cells via Suppressing IKBKE/NF-κB Pathway
por: Wang, Lingyan, et al.
Publicado: (2017)

Upregulation of endogenous TRAIL-elicited apoptosis is essential for metformin-mediated antitumor activity against TNBC and NSCLC
por: Liu, Shuang, et al.
Publicado: (2021)

Differential activity of GSK-3 isoforms regulates NF-κB and TRAIL- or TNFα induced apoptosis in pancreatic cancer cells
por: Zhang, J-S, et al.
Publicado: (2014)

Differential activity of GSK-3 isoforms regulates NF-κB and TRAIL- or TNFα induced apoptosis in pancreatic cancer cells
por: Zhang, J-S, et al.
Publicado: (2014)

MicroRNA-145 Increases the Apoptosis of Activated Hepatic Stellate Cells Induced by TRAIL through NF-κB Signaling Pathway
por: Yang, Junfa, et al.
Publicado: (2018)

The Third-Generation EGFR Inhibitor, Osimertinib, Promotes c-FLIP Degradation, Enhancing Apoptosis Including TRAIL-Induced Apoptosis in NSCLC Cells with Activating EGFR Mutations
por: Shi, Puyu, et al.
Publicado: (2019)

CREB1 Transcriptionally Activates LTBR to Promote the NF-κB Pathway and Apoptosis in Lung Epithelial Cells
por: Hu, Zhengyun, et al.
Publicado: (2022)

ShDcR3 sensitizes TRAIL-resistant HCC cells by inducing caspase-dependent apoptosis while suppressing NF-κB dependent cFLIP(L) expression
por: Liang, Dong-Yu, et al.
Publicado: (2018)

Synergism of ursolic acid and cisplatin promotes apoptosis and enhances growth inhibition of cervical cancer cells via suppressing NF-κB p65
por: Li, Lan, et al.
Publicado: (2017)

Inhibition of NF-κB Pathway and Modulation of MAPK Signaling Pathways in Glioblastoma and Implications for Lovastatin and Tumor Necrosis Factor-Related Apoptosis Inducing Ligand (TRAIL) Combination Therapy
por: Liu, Pi Chu, et al.
Publicado: (2017)

Lambertianic Acid Sensitizes Non-Small Cell Lung Cancers to TRAIL-Induced Apoptosis via Inhibition of XIAP/NF-κB and Activation of Caspases and Death Receptor 4
por: Ahn, Deok Soo, et al.
Publicado: (2018)

Protective autophagy decreases lorlatinib cytotoxicity through Foxo3a-dependent inhibition of apoptosis in NSCLC
por: Lu, Conghua, et al.
Publicado: (2022)

NF-κB suppresses apoptosis and promotes bladder cancer cell proliferation by upregulating survivin expression in vitro and in vivo
por: Cui, Xiaolu, et al.
Publicado: (2017)

Kallistatin Suppresses Cell Proliferation and Invasion and Promotes Apoptosis in Cervical Cancer Through Blocking NF-κB Signaling
por: Wang, Tao, et al.
Publicado: (2017)

NKILA inhibits NF-κB signaling and suppresses tumor metastasis
por: Ke, Shun, et al.
Publicado: (2018)

NF-κB Inhibition Suppresses Experimental Melanoma Lung Metastasis
por: Stansel, Tomoko, et al.
Publicado: (2020)

The adaptor protein FADD and the initiator caspase-8 mediate activation of NF-κB by TRAIL
por: Grunert, M, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_o2cii7od05brm2rdrg1tvgumsv